Luxna Biotech Co., Ltd.

  • EN
  • JP

Luxna Biotech Co., Ltd.

  • About
  • Oligonucleotide Therapeutics
  • Technology
  • Business Structure
  • News
  • Open Positions
  • Access
  • Contact
ルクサナバイオテク株式会社
  • About
  • Oligonucleotide Therapeutics
  • Technology
  • Business Structure
  • News
  • Open Positions
  • Access
  • Contact

News

  1. HOME
  2. News

We will make a presentation at the 5th Annual Meeting of Nucleic Acids Therapeutics Society of Japan.

  • 2019/07/03
  • Event
Read

Notice of Office Relocation

  • 2019/05/30
  • Notice
Read

Our Technical Adviser, Prof. Satoshi Obika, and our President & CEO, Mr. Hideaki Sato, will participate in an event “Innovators’ Meeting” as a panelist.

  • 2019/02/01
  • Event
Read

Our President & CEO, Mr. Hideaki Sato, will participate in an event “Start Pitch! Kansai” as a speaker.

  • 2019/01/25
  • Event
Read

License Agreement concluded with Aligos Therapeutics, Inc.

  • 2019/01/22
  • Notice
Read

Our official website revamped.

  • 2018/12/14
  • Notice

Strategic cooperation agreement concluded with Open Circle Partners LLC.

  • 2018/09/02
  • Notice
Read

We will be joint exhibitors with NPO Kinki Bio-industry Development Organization at Bio Japan 2018.

  • 2018/08/22
  • Event
Read

Oligonucleotides Therapeutics Discovery Collaboration Agreement concluded with Nissan Chemical Co., Ltd.

  • 2018/07/06
  • Notice
Read

Our article was posted on Nikkei Biotech ONLINE.

  • 2018/07/03
  • Interview
Read
  • Prev
  • 9
  • 10
  • 11
  • 12
  • Next

Luxna Biotech Co., Ltd.

  • C907 9F Bldg. C, Techno-Alliance Complex, 2-8 Yamadaoka, Suita, Osaka 565-0871 JAPAN
  • TEL: +81(0)6-6170-1228
  • FAX: +81(0)6-6170-2207
  • MAIL: info@luxnabiotech.co.jp
  • About
  • Oligonucleotide Therapeutics
  • Technology
  • Business Structure
  • News
  • Open Positions
  • Company Overview
  • Contact
  • Animal Experiments Policy
  • Privacy Protection Policy
  • Site Map

Copyright © 2018 Luxna Biotech Co., Ltd. All Rights Reserved.